Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Deutsche Bank $1.5 billion notes offering
The fixed-to-floating-rate eligible liabilities notes are due 2031
Corteva $500 million senior notes offering
The investment-grade notes are due 2032
Nextracker acquisition of Bentek
We advised Nextracker on the acquisition
Orbia $1.1 billion notes offering
We advised Orbia on the investment-grade debt offering
Somnigroup International $953 million secondary offering
The shares are listed on the New York Stock Exchange
Middlesex Water $110 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
CytomX Therapeutics $100 million stock offering
The stock is listed on the Nasdaq Global Select Market
Bank of America $5 billion floating-rate and fixed-to-floating-rate notes
The investment-grade debt offering is based on the Secured Overnight Financing Rate
Bank of America $3 billion preferred stock offering
The company issued depositary shares representing interests in fixed-rate reset non-cumulative preferred stock
Auna $62.1 million senior secured notes offering
We advised Auna on the offering